Novel autosomal dominant TPM3 mutation causes a combined congenital fibre type disproportion-cap disease histological pattern.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
08 2022
Historique:
received: 09 12 2021
revised: 16 04 2022
accepted: 26 05 2022
pubmed: 11 6 2022
medline: 19 8 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

Tropomyosin 3 (TPM3) gene mutations associate with autosomal dominant and recessive nemaline myopathy 1 (NEM1), congenital fiber type disproportion myopathy (CFTD) and cap myopathy (CAPM1), and a combination of caps and nemaline bodies. We report on a 47-year-old man with polyglobulia, restricted vital capacity and mild apnea hypopnea syndrome, requiring noninvasive ventilation. Physical assessment revealed bilateral ptosis and facial paresis, with high arched palate and retrognathia; global hypotonia and diffuse axial weakness, including neck and upper and lower limb girdle and foot dorsiflexion weakness. Whole body MRI showed a diffuse fatty replacement with an unspecific pattern. A 122 gene NGS neuromuscular disorders panel revealed the heterozygous VUS c.709G>A (p.Glu237Lys) on exon 8 of TMP3. A deltoid muscle biopsy showed a novel histological pattern combining fiber type disproportion and caps. Our findings support the pathogenicity of the novel TPM3 variant and widen the phenotypic gamut of TMP3-related congenital myopathy.

Identifiants

pubmed: 35688744
pii: S0960-8966(22)00162-6
doi: 10.1016/j.nmd.2022.05.014
pii:
doi:

Substances chimiques

TPM3 protein, human 0
Tropomyosin 0

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

687-691

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jorge A Bevilacqua (JA)

Unidad Neuromuscular, Departamento Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago, Chile; Departamento de Anatomía y Medicina Legal, Facultad de Medicina, Universidad de Chile. Santiago, Chile; Unidad de Patología Neuromuscular, Departamento de Neurología y Neurocirugía, Clínica Dávila, Santiago, Chile. Electronic address: jbevilac@med.uchile.cl.

Juan Pablo Contreras (JP)

Unidad Neuromuscular, Departamento Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago, Chile; Departamento de Especialidades, Facultad de Medicina, Universidad de Concepción, Concepción, Chile; Servicio Neurología, Hospital Clínico Regional de Concepción: "Dr. Guillermo Grant Benavente", Concepción, Chile.

Alejandra Trangulao (A)

Departamento de Anatomía y Medicina Legal, Facultad de Medicina, Universidad de Chile. Santiago, Chile; Unidad de Patología Neuromuscular, Departamento de Neurología y Neurocirugía, Clínica Dávila, Santiago, Chile.

Úrsula Hernández (Ú)

Unidad Neuromuscular, Departamento Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago, Chile; Equipo de Neurología, Servicio de Medicina. Hospital San Juan de Dios La Serena, La Serena, Chile.

Guy Brochier (G)

Unité Morphologie Neuromusculaire, Institut de Myologie, GHU Pitié-Salpêtrière, Paris, France.

Jorge Díaz (J)

Centro de Imagenología, Hospital Clínico Universidad de Chile, Santiago, Chile.

Ricardo Hughes (R)

Unidad Neuromuscular, Departamento Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago, Chile.

Mario Campero (M)

Unidad Neuromuscular, Departamento Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago, Chile.

Norma B Romero (NB)

Unité Morphologie Neuromusculaire, Institut de Myologie, GHU Pitié-Salpêtrière, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH